Esther Odekunle

Esther A. Odekunle is a British Neurobiologist and Antibody Engineer. She works as an antibody engineer for the pharmaceutical company GlaxoSmithKline (GSK), where her research focuses on identifying and removing physical and chemical risks from therapeutic antibodies to improve their viability as medications. She also promotes the visibility of diverse professionals in STEM.

Early life and education

Odekunle was born the youngest of her siblings and raised in the United Kingdom by Nigerian parents who had emigrated to the UK. She was inspired by her teachers while growing up and by books on animals and the human body, encouraging her interest in science from a young age. After initially considering a career in medicine, she earned both the B.S. in biochemistry and Ph.D. in neurobiology from Queen Mary University of London. Her doctoral work at Queen Mary focused on neuropeptide systems in starfish, culminating in her 2018 thesis. Discovery and Characterisation of Vasopressin/Oxytocin-type Signalling in an Echinoderm and a Xenacoelomorph . She chose to work on starfish because of little-understood abilities such as regeneration. After having worked with mice and rats as an undergraduate, she was also encouraged by the fact that starfish do not bite. She took a year off between degree programs and received full funding for her doctoral work from the Society for Experimental Biology.

Career

Odekunle's goal in academia was not to remain there as a professor, but rather to "explore a specific scientific area in great depth and contribute to the scientific field" and eventually to apply her scientific skills to therapeutics., noting that her passion lay in exploring receptor-ligand interactions at an amino acid level to drive medicine discovery . As an antibody engineer at GSK, she works to clone antibodies from B cells and optimize them as potential targeted treatments for specific disease targets such as cancers, viral infections, and bacterial infections

Publications